Critical Evaluation of Drug Advertisements in a Medical College in Lalitpur, Nepal

References

• Mali SN, Dudhgaonkar S, Bachewar NP. Evaluation of rationality of promotional drug literature using World Health Organization guidelines. Indian J Pharmacol. 2010;42(5):267‐272. doi:10.4103/0253-7613.70020
   Web of Science ®Google Scholar
• Phoolgen S, Kumar SA, Kumar RJ. Evaluation of the rationality of psychotropic drug promotional literatures in Nepal. J Drug Discov Ther. 2012;2:6–8.
   Google Scholar
• Gopalakrishnan S, Murali R. India: Campaign to tackle unethical promotion. Essential drugs monitor. [Online]; 2002. Available from: http://www.apps.who.int/medicinedocs/pdf/s4937e/s4937e.pdf.
   Google Scholar
• Giri BR, Shankar PR. Learning how drug companies promote medicines in Nepal. PLoS Med. 2005;2(8):e256. doi:10.1371/journal.pmed.0020256
   Web of Science ®Google Scholar
• Kornfield R, Donohue J, Berndt ER, Alexander GC. Promotion of prescription drugs to consumers and providers, 20012010. PLoS One. 2013;8:e55504. doi:10.1371/journal.pone.0055504
   PubMed Web of Science ®Google Scholar
• Rivera SM, Gilman AG. Drug invention and the pharmaceutical industry. In: Knollman B, Chabner B, Brunton L, editors. Goodman & Gilman’s the Pharmacological Basis of Therapeutics. New York: McGraw-Hill Medical; 2011:3–16.
   Google Scholar
• Ethical criteria for medicinal drug promotion. World Health Organization [Online]; 1988 [Cited May 13; [ 8 screens]. Available from: http://www.who.int/medicinedocs/collect/edmweb/pdf/whozip08e/whozip08e.pdf.
   Google Scholar
• Department of Drug Administration, Kathmandu, Nepal. Guidelines on Ethical Promotion of Medicine. 2007. Unofficial draft document.
   Google Scholar
• Department of Drug Administration (NP). Drug Act, 2035 [statute on the internet] Nepal: ministry of Health; 1978; [ cited 2017]. Available from: http://www.lawcommission.gov.np/en/?s=Drug±act±1978.
   Google Scholar
• Jadav SS, Dumatar CB, Dikshit RK. Drug promotional literatures (DPLs) evaluation as per World Health Organisation (WHO) criteria. J App Pharm Sci. 2014;4:84–88.
   Google Scholar
• Alam K, Shah AK, Ojha P, Palaian S, Shankar PR. Evaluation of drug promotional materials in a hospital setting in Nepal. South Med Rev. 2009;2:2–6.
   PubMedGoogle Scholar
• Prasad P, Bajracharya SR, Deo S, et al. Adherence of drug promotional literatures distributed by pharmaceutical companies to World Health Organization ethical criteria for medicinal drug promotion. J Nepal Health Res Counc. 2019;17(44):345–350. doi:10.33314/jnhrc.v17i3.1840
   Google Scholar
• Santiago MG, Bucher HC, Nordmann AJ. Accuracy of drug advertisements in medical journals under new law regulating the marketing of pharmaceutical products in Switzerland. BMC Med Inform Decis Mak. 2008;8:16. doi:10.1186/1472-6947-8-61
   Web of Science ®Google Scholar
• Understanding and responding pharmaceutical promotion. A practical guide. World Health Organization/Health Action International collaborative project. Available from: https://haiweb.org/wp-content/uploads/2015/05/Pharma-Promotion-Guide-English.pdf.
   Google Scholar
• Al-Tuhaifi TM, Awad AM, Abu-Zaid A, et al. Assessment of consistency between claims and references referred to in pharmaceutical advertising brochures in the Kingdom of Saudi Arabia. Cureus. 2019;11(1):e3907. doi:10.7759/cureus.3907
   Web of Science ®Google Scholar
• World Health Organization. WHO model list of essential medicines; 2017. Available from: https://www.who.int/medicines/publications/essentialmedicines/en/.
   Google Scholar
• Rohra DK, Gilani AH, Memon IK, et al. Critical evaluation of claims made by pharmaceutical companies in drug promotional material in Pakistan. J Pharm Pharm Sci. 2006;9:50–59.
   Web of Science ®Google Scholar
• Angsulee NK. A participatory evaluation of the implementation of WHO’s ethical criteria for medical drug promotion in multiple countries. Final report; 2004. Available from: https://scholar.google.com/scholar_lookup?journal=Final±Report&title=A±participatory±evaluation±of±the±implementation±of±WHO’s±ethical±criteria±for±medical±drug±promotion±in±multiple±countries&author=NK±Angsulee&publication_year=2004&.
   Google Scholar
• Othman N, Vitry A, Roughead EE. Quality of pharmaceutical advertisements in medical journals: a systematic review. PLoS One. 2009;4(7:e6350. doi:10.1371/journal.pone.0006350.
   PubMed Web of Science ®Google Scholar
• Harper I, Rawal N, Subedi M. Disputing distribution: ethics and pharmaceutical regulation in Nepal. Stud Nepali Hist Soc. 2011;16(1):1–39.
   Google Scholar
• Khakhkhar T, Mehta M, Shah R, Sharma D. Evaluation of drug promotional literatures using WHO guidelines. J Pharm Negative Results. 2013;4(1):33–38. doi:10.4103/0976-9234.116770
   Google Scholar
• Department of Drug Administration (NP). Drug Category Rules, 2043 [statute on the internet] Nepal: ministry of Health; 1986 [cited 2018]. Available from: http://www.dda.gov.np/content/drug-standard-regulation-2043.
   Google Scholar
• Bbosa GS, Mwebaza N, Odda J, Kyegombe DB, Ntale M. Antibiotics/antibacterial drug use, their marketing and promotion during the post-antibiotic golden age and their role in emergence of bacterial resistance. Health. 2014;6(05):410–425. doi:10.4236/health.2014.65059
   Google Scholar
• Jaykaran YP, Kantharia ND, Saxena D. Gender and racial bias in drug promotional material distributed by pharmaceutical companies. J Pharmacol Pharmacother. 2012;3(1):55‐56. doi:10.4103/0976-500X.92517
   Google Scholar
• Cooper RJ, Schriger DL. The availability of references and the sponsorship of original research cited in pharmaceutical advertisements. CMAJ. 2005;172:487–491. doi:10.1503/cmaj.1031940
   Web of Science ®Google Scholar
• Thunander Sundbom L, Bingefors K, Hedborg K, Isacson D. Are men under-treated and women over-treated with antidepressants? Findings from a cross-sectional survey in Sweden. B J Psych Bull. 2017;41(3):145‐150. doi:10.1192/pb.bp.116.054270
   Google Scholar
• Nepalese National Formulary. Third edition. Kathmandu, Nepal. ISBN: 978-9937-0-4337-3. Published by Department of DrugAdministration; 2018
   Google Scholar
• Islam MS, Farah SS. Misleading promotion of drugs in Bangladesh: evidence from drug promotional brochures distributed to general practitioners by the pharmaceutical companies. J Public Health. 2007;29(2):212‐213. doi:10.1093/pubmed/fdm024
   Web of Science ®Google Scholar
• Vyas N, Shahani S. Analysis of drug promotional literatures in a tertiary care hospital: a cross sectional study. Int J Basic Clin Pharmacol. 2019;8(5):1102–1105. doi:10.18203/2319-2003.ijbcp20191608
   Google Scholar
• Wzorek LF, Correr CJ, Trindade ACB, Pontarolo R. Analysis of medicine advertisement produced in Brazil. Pharm Pract. 2007;5(3):105‐8.
   Google Scholar
• Mejía R, Avalos A. Printed material distributed by pharmaceutical propaganda agents. Medicina. 2001;61(3):315‐8.
   Web of Science ®Google Scholar